9 completed, 5 active not recruiting, 2 recruiting, 2 terminated. 21 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 21 | Completed 9, Active not recruiting 5, Recruiting 2, Terminated 2, Unknown 2, Not yet recruiting 1 |
| Phase 2 | 3 | Active not recruiting 2, Unknown 1 |
Follow Pregnancy Related: new trials by email Literature Review of Pregnancy Related trials Research Report on Pregnancy Related
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial Iron Folic Acid Tablets with 60 mg of iron, Multiple Micronutrient Supplements with 60 mg of elemental iron - Pregnancy Related | Phase 3 | Not yet recruiting | George Washington University | 130 | 2027-06-01 | 2026-06-04 |
| Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Multiple Micronutrient Supplements with 30 mg of elemental iron, Multiple Micronutrient Supplements with 45 mg of elemental iron, Multiple Micronutrient Supplements with 60 mg of elemental iron - Pregnancy Related | Phase 3 | Active not recruiting | George Washington University | 156 | 2025-09-26 | 2026-05-08 |
| Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Multiple Micronutrient Supplements with 30 mg of elemental iron, Multiple Micronutrient Supplements with 45 mg of elemental iron, Multiple Micronutrient Supplements with 60 mg of elemental iron - Pregnancy Related | Phase 3 | Recruiting | George Washington University | 6381 | 2025-03-03 | 2026-07-14 |
| Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens Levonorgestrel, Mifepristone - Pregnancy Early, Pregnancy Related | Phase 2 / Phase 3 | Unknown | Gynuity Health Projects | 286 | 2024-07-22 | 2024-07-18 |
| Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE) Buprenorphine Transdermal Matrix Patch, Sham patch - Opioid Use Disorder, Pregnancy Related | Phase 3 | Completed | Washington University School of Medicine | 7 | 2023-11-27 | 2026-09-10 |
| Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women MWSH plus Candlelit Care, MWSH - Pregnancy Related, Pregnancy Complications | Phase 2 / Phase 3 | Active not recruiting | Cedars-Sinai Medical Center | 150 | 2023-06-01 | 2026-10-22 |
| SAINT: Safe Induction of Labor Trial Buscopan 20 MG/ML Injectable Solution, Sodium bicarbonate, Placebo - Labor Complication, Induced; Birth | Phase 3 | Recruiting | Oslo University Hospital | 3000 | 2023-01-03 | 2024-04-04 |
| Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy Dihydroartemisinin-Piperaquine (DP), Sulfadoxine pyrimethamine (SP) - Malaria, Malaria in Pregnancy | Phase 3 | Active not recruiting | Menzies School of Health Research | 1172 | 2022-08-31 | 2025-06-06 |
| DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women Dolutegravir plus lamivudine in a FDC - HIV Infections, Pregnancy Related | Phase 3 | Completed | Fundação Bahiana de Infectologia | 20 | 2021-07-01 | 2023-10-04 |
| Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia Ferumoxytol Injection [Feraheme], Ferrous Sulfate - Pregnancy Related, Anemia, Iron Deficiency | Phase 3 | Completed | Stanford University | 83 | 2021-01-21 | 2026-06-30 |
| Opioid Prescription After Cesarean Trial 0 to 20 tablets of oxycodone 5mg, Fixed opioid prescription - Pregnancy Related, Opioid Use | Phase 3 | Completed | The George Washington University Biostatistics Center | 5521 | 2020-09-21 | 2023-10-03 |
| Natural Versus Programmed Frozen Embryo Transfer (NatPro) Modified natural cycle, Programmed cycle - Pregnancy Related, Pre-Eclampsia | Phase 3 | Active not recruiting | JHSPH Center for Clinical Trials | 788 | 2020-09-16 | 2025-05-16 |
| Medication Treatment for Opioid Use Disorder in Expectant Mothers Buprenorphine Injection, Buprenorphine Sublingual Product - Opioid-Related Disorders, Drug Addiction | Phase 3 | Completed | T. John Winhusen, PhD | 140 | 2020-07-21 | 2026-06-04 |
| Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum Hydroxychloroquine, Placebo - Pregnancy Related, COVID | Phase 3 | Completed | Barcelona Institute for Global Health | 129 | 2020-05-13 | 2022-01-12 |
| Sleep Apnea and Fetal Growth Restriction S9 VPAP Adapt - Obstructive Sleep Apnea, Fetal Growth Restriction | Phase 3 | Terminated | Washington University School of Medicine | 3 | 2019-11-18 | 2022-03-09 |
| Improving Maternal heAlth by Reducing Malaria in African HIV Women Dihydroartemisinin-piperaquine (DHA-PPQ), Placebo Oral Tablet - Malaria, HIV/AIDS | Phase 3 | Completed | Barcelona Institute for Global Health | 666 | 2019-09-18 | 2024-10-01 |
| Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy Daily 500 mg elemental calcium as calcium carbonate, Daily1500 mg elemental calcium as calcium carbonate - Pregnancy Related | Phase 3 | Completed | Harvard School of Public Health (HSPH) | 22000 | 2018-11-30 | 2024-12-24 |
| Dolutegravir in Pregnant HIV Mothers and Their Neonates Dolutegravir, Standard of Care (EFV + 2 NRTI backbone) - HIV-1-infection, Pregnancy Related | Phase 3 | Completed | University of Liverpool | 268 | 2018-01-22 | 2025-02-21 |
| Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section Alternate Management, Control - Pregnancy Related, Narcotic Use | Phase 3 | Terminated | Brest, Norman A., M.D. | 1494 | 2017-10-04 | 2021-03-02 |
| Pentaerithrityl Tetranitrate (PETN) for Secondary Prevention of Intrauterine Growth Restriction Pentalong, Placebos - Fetal Growth Retardation, Pregnancy Related | Phase 3 | Unknown | Jena University Hospital | 324 | 2017-07-26 | 2021-02-25 |
Showing 20 of 21. Sign in to see all of them.
Anemia (2) · Fetal Growth Retardation (2) · Malaria (2) · Opioid-Related Disorders (2) · Pregnancy Complications (2) · Acquired Immunodeficiency Syndrome (1) · Anemia, Iron-Deficiency (1) · Anxiety Disorders (1) · COVID-19 (1) · Coronavirus Infections (1) · Depression (1) · Depression, Postpartum (1) · HIV Infections (1) · Infertility (1) · Inflammation (1)
Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (6) · Infections (4) · Pathological Conditions, Signs and Symptoms (4) · Pregnancy Complications (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genital Diseases (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Mental Disorders (3) · Pathologic Processes (3) · RNA Virus Infections (3) · Virus Diseases (3) · Blood-Borne Infections (2) · Chemically-Induced Disorders (2)
dolutegravir (2) · Buprenorphine (1) · Buprenorphine, Naloxone Drug Combination (1) · Butylscopolammonium Bromide (1) · Calcium (1) · Calcium Carbonate (1) · Enhanced Recovery After Surgery (1) · Ferrosoferric Oxide (1) · Hydroxychloroquine (1) · Iron (1) · Lamivudine (1) · Levonorgestrel (1) · Mifepristone (1) · Oxycodone (1) · Sodium Bicarbonate (1)
George Washington University (3) · Barcelona Institute for Global Health (2) · Washington University School of Medicine (2) · Brest, Norman A., M.D. (1) · Cedars-Sinai Medical Center (1) · Centre For International Health (1) · Fundação Bahiana de Infectologia (1) · Gynuity Health Projects (1) · Harvard School of Public Health (HSPH) (1) · JHSPH Center for Clinical Trials (1) · Jena University Hospital (1) · Menzies School of Health Research (1) · Oslo University Hospital (1) · Stanford University (1) · T. John Winhusen, PhD (1)
United States (8) · Tanzania (3) · Brazil (1) · Gabon (1) · Germany (1) · India (1) · Israel (1) · Mozambique (1) · Nepal (1) · Norway (1) · Papua New Guinea (1) · South Africa (1) · Spain (1) · Uganda (1)
Blair Wylie, MD, MPH (3) · Christopher R Sudfeld, ScD, ScM (3) · Emily R Smith, ScD, MPH (3) · Honorati Masanja, PhD (3) · Alfa Muhihi, PhD (2) · Andrea Pembe, MD, MMed, PhD, FCOG (2) · Alexander Hincker, MD (1) · Alfa Muhihi, MD, MPH (1) · Andreas Pembe, MD, MMed, PhD, FCOG (1) · Beverly Winikoff, MD, MPH (1) · Clara Menendez, MD, PhD (1) · Deirdre Lyell (1) · Holger Unger, PhD MBChB (1) · Irogue Igbinosa, MD (1) · James Segars, MD (1)
PMID 28851784, PMID 31521118, PMID 32386721, PMID 32616063, PMID 34187829, PMID 34815285, PMID 34819147, PMID 35672853, PMID 35905752, PMID 37023858, PMID 37031691, PMID 38098221, PMID 38197817, PMID 38224706, PMID 38460823, PMID 38857509, PMID 38997229, PMID 39105509, PMID 39324693, PMID 40032397, PMID 40517226, PMID 40639854, PMID 40643178, PMID 41015387, PMID 41429292, PMID 41461260, PMID 41493372, PMID 41837971, PMID 41860281, PMID 42067065, PMID 42203269, PMID 42283563
K12HD103084 (1), R21MD017396 (1), U24HD036801 (1), UG1DA013732 (1), UG1HD027869 (1), UG1HD027915 (1), UG1HD034208 (1), UG1HD040485 (1), UG1HD040500 (1), UG1HD040512 (1), UG1HD040544 (1), UG1HD040545 (1), UG1HD040560 (1), UG1HD053097 (1), UG1HD087192 (1)